Literature DB >> 7884901

Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation.

P W Dini1, J T Eltman, J S Lipsick.   

Abstract

The v-Myb protein encoded by avian myeloblastosis virus causes oncogenic transformation of monoblastic cells committed to the monocyte/macrophage lineage. v-Myb is a doubly truncated form of its normal cellular counterpart, c-Myb. In addition to its N- and C-terminal deletions, v-Myb contains a number of amino acid substitutions relative to c-Myb. We have previously shown that neither overexpression of c-Myb nor introduction of these amino acid substitutions into c-Myb is sufficient for transformation of myelomonocytic cells. However, a doubly truncated form of c-Myb which lacked these substitutions transformed myeloblastic cells that appeared to be committed to the granulocytic pathway. We demonstrate here that mutations in both the DNA-binding and transcriptional activation domains of v-Myb are required for transformation of rapidly growing monoblasts rather than more slowly growing myeloblasts. These rapidly growing monoblasts do not express mim-1, a target gene for the Gag-Myb-Ets protein of E26 leukemia virus, or C/EBP proteins which cooperate with Myb to activate mim-1 expression. Furthermore, v-Myb proteins which contain both sets of these mutations are weaker transcriptional activators relative to proteins which lack these mutations. These results support a model in which amino acid substitutions in v-Myb have been selected for their ability to activate only a subset of those genes which can be activated by a doubly truncated form of c-Myb. In particular, mim-1 appears to represent a class of genes whose expression was selected against during the development of an increasingly virulent strain of avian myeloblastosis virus by passage in animals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884901      PMCID: PMC188928     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues.

Authors:  T J Gonda; D K Sheiness; J M Bishop
Journal:  Mol Cell Biol       Date:  1982-06       Impact factor: 4.272

2.  Focus assay and defectiveness of avian myeloblastosis virus.

Authors:  C Moscovici; L Gazzolo; M G Moscovici
Journal:  Virology       Date:  1975-11       Impact factor: 3.616

3.  Two cell lines from lymphomas of Marek's disease.

Authors:  Y Akiyama; S Kato
Journal:  Biken J       Date:  1974-09

4.  Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types.

Authors:  S A Ness; E Kowenz-Leutz; T Casini; T Graf; A Leutz
Journal:  Genes Dev       Date:  1993-05       Impact factor: 11.361

5.  The Myb DNA-binding domain is highly conserved in Dictyostelium discoideum.

Authors:  U Stober-Grässer; B Brydolf; X Bin; F Grässer; R A Firtel; J S Lipsick
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

6.  Differential transcriptional activation by v-myb and c-myb in animal cells and Saccharomyces cerevisiae.

Authors:  R H Chen; J S Lipsick
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

7.  Cellular sequences are present in the presumptive avian myeloblastosis virus genome.

Authors:  L M Souza; J N Strommer; R L Hillyard; M C Komaromy; M A Baluda
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

8.  Individual repeats of Drosophila Myb can function in transformation by v-Myb.

Authors:  X Bin; J S Lipsick
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Chicken "erythroid" cells transformed by the Gag-Myb-Ets-encoding E26 leukemia virus are multipotent.

Authors:  T Graf; K McNagny; G Brady; J Frampton
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

10.  Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo.

Authors:  P W Dini; J S Lipsick
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

View more
  12 in total

1.  FAETL motif required for leukemic transformation by v-Myb.

Authors:  S L Fu; J S Lipsick
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  Functional analysis of carboxy-terminal deletion mutants of c-Myb.

Authors:  D M Wang; J W Dubendorff; C H Woo; J S Lipsick
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1.

Authors:  Wanli Lei; Fan Liu; Scott A Ness
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

4.  Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.

Authors:  Xianming Mo; Elisabeth Kowenz-Leutz; Yves Laumonnier; Hong Xu; Achim Leutz
Journal:  Genes Dev       Date:  2005-09-29       Impact factor: 11.361

5.  Cells transformed by a v-Myb-estrogen receptor fusion differentiate into multinucleated giant cells.

Authors:  U Engelke; D M Wang; J S Lipsick
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Myb-induced chromatin remodeling at a dual enhancer/promoter element involves non-coding rna transcription and is disrupted by oncogenic mutations of v-myb.

Authors:  Carola Wilczek; Olesya Chayka; Annette Plachetka; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

7.  Overexpression of an alternatively spliced form of c-Myb results in increases in transactivation and transforms avian myelomonoblasts.

Authors:  C H Woo; L Sopchak; J S Lipsick
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

8.  Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.

Authors:  Yoshitsugu Mitani; Bin Liu; Pulivarthi H Rao; Vishnupriya J Borra; Mark Zafereo; Randal S Weber; Merrill Kies; Guillermina Lozano; P Andrew Futreal; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2015-12-02       Impact factor: 12.531

Review 9.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

10.  Myb proteins inhibit fibroblast transformation by v-Rel.

Authors:  Shu-Ling Fu; Brigitte Ganter; Joseph S Lipsick
Journal:  Mol Cancer       Date:  2006-11-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.